The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.

Sam KantAdam MorrisSrekar RaviLauren FloydEric GapudBrendan AntichosAjay DhaygudePhil SeoDuvuru Geetha

Published in: Journal of nephrology (2020)

The incidence of COVID-19 in patients with AAV appears to be similar to that of the general population. For a patient population that requires active clinical surveillance, there is significant disruption in care as a result of the pandemic. Reduction of immunosuppression may not be indicated, and the risk of relapse likely far outweighs the risk of COVID-19.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
healthcare
palliative care
risk factors
public health
case report
pain management
free survival
chronic pain